A family history of pancreatic cancer

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 3, Issue 10, 2006, Pages 586-591

  Keswani, Rajesh N ^a   Noffsinger, Amy ^a   Waxman, Irving ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY HISTORY; FOLLOW UP; GENETIC COUNSELING; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; PANCREAS CANCER; PANCREAS RESECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; CARCINOMA IN SITU; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; FAMILY; HUMANS; MALE; MEDICAL RECORDS; PANCREATECTOMY; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749338222     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0604     Document Type: Article

References (20)

1. Rulyak SJ et al. (2003) Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 57: 23-29
2. Klein AP et al. (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64: 2634-2638
3. Klein AP et al. (2002) Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 23: 133-149
4. Lynch HT et al. (1996) Familial pancreatic cancer: A review. Semin Oncol 23: 251-275
5. Schenk M et al. (2001) Familial risk of pancreatic cancer. J Natl Cancer Inst 93: 640-644
6. Lowenfels AB et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89: 442-446
7. Rulyak SJ et al. (2003) Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome. Cancer 98: 798-804
8. Hahn SA et al. (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95: 214-221
9. Murphy KM et al. (2002) Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res 62: 3789-3793
10. Kim JE et al. (2004) Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 19: 182-186
11. Hruban RH et al. (2001) Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer. Dig Dis 19: 76-84
12. Saisho H and Yamaguchi T (2004) Diagnostic imaging for pancreatic cancer: Computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 28: 273-278
13. Hall Pde L et al. (2002) Premalignant conditions of the pancreas. Pathology 34: 504-517
14. Hruban RH et al. (2000) Progression model for pancreatic cancer. Clin Cancer Res 6: 2969-2972
15. Brentnall TA et al. (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131: 247-255
16. Canto MI et al. (2006) Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study. Clin Gastroenterol Hepatol 4: 766-781
17. Rulyak SJ and Brentnall TA (2001) Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 1: 477-485
18. Rulyak SJ and Brentnall TA (2004) Inherited pancreatic cancer: improvements in our understanding of genetics and screening. Int J Biochem Cell Biol 36: 1386-1392
19. Charpentier KP et al. (2004) A new indication for pancreas transplantation: High grade pancreatic dysplasia. Clin Transplant 18: 105-107
20. Amundadottir LT et al. (2004) Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1: E65